Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Improved microtubule-inhibitory anticancer agents in development

May 23, 1997

NeoPharm reports on antisense liposomes which inhibit Raf-1 proteins

May 23, 1997

Oxford GlycoSciences receives U.K. approval to commence trials on novel nucleoside analogue

May 22, 1997

Enrollment complete for phase II trial of lisofylline in AML

May 22, 1997

Phase I results with Isis antisense anticancer drug reported at ASCO

May 22, 1997

Pharmacyclics reports phase I results for Lu-Tex

May 22, 1997

Interim results with Pharmacyclics' Gd-Tex reported at ASCO

May 22, 1997

Encouraging results reported for ImClone's lead cancer therapeutic agent

May 22, 1997

Onyx reports clinical results of anticancer viral therapeutic at ASCO meeting

May 22, 1997

Diaziridinylpolyamines as anticancer agents claimed by U. of Maryland

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...